Good practices for modelling the cost-effectiveness of antipsychotic medications.

Figshare2020-07-10 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Good_practices_for_modelling_the_cost-effectiveness_of_antipsychotic_medications_/12640827 数据链接链接失效反馈

官方服务：

资源简介：

Good practices for modelling the cost-effectiveness of antipsychotic medications.

创建时间：

2020-07-10

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study - supplementary table

心衰治疗成本分析

药物经济学评估

Aim: Compare heart failure (HF) costs of Furoscix use at home compared with inpatient intravenous (IV) diuresis. Patients & methods: Prospective, case control study of chronic HF pat

DataCite Commons2024-05-17 更新100

Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study

药物经济学评估

肺癌靶向治疗可及性

ABSTRACT BACKGROUND: Lung cancer is the fourth most common cancer in Brazil. In the 2000s, better understanding of molecular pathways led to development of epidermal growth factor receptor (EGFR)-ta

NIAID Data Ecosystem20

Differences in healthcare resource utilization and direct medical costs of patients with rheumatoid arthritis (RA) before and after the use of multiple biologic agents-Switched.

药物经济学评估

类风湿关节炎治疗管理

Differences in healthcare resource utilization and direct medical costs of patients with rheumatoid arthritis (RA) before and after the use of multiple biologic agents-Switched.

Figshare2018-07-18 更新10

Additional file 2 of Development of a pharmacoeconomic registry: an example using hormonal contraceptives

药物经济学评估

避孕药成本效益

Additional file 2.

Figshare2021-03-20 更新30

Table 1_Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis.docx

药物经济学评估

COVID-19治疗

IntroductionRemdesivir (RDV) and nirmatrelvir/ritonavir (NRM/RTV) are two antiviral agents for treating outpatient adults with mild to moderate symptomatic COVID-19 at high risk of developing a severe

NIAID Data Ecosystem10

Good practices for modelling the cost-effectiveness of antipsychotic medications.

资源简介：

相关数据集